[Renal transplantation in children].
Despite being considered a high risk procedure, renal transplantation has been recognized for more than 20 years as the best therapeutic option for children with end-stage renal disease since it is superior than any available dialytic procedure in improving the neuropsychological development and the quality of life. Today pediatric patients have similar graft survival than adults, and 10 year-old children or less have better outcome than any other age group. These remarking results are due to the development of specialized pediatric transplant centers and research programs, improvement in the selection and preparation of donors and recipients, refinement of the surgical technique and the use of new immunossupressive drugs.
Medeiros-Domingo
Mara
M
Departamento de Nefrología, Hospital Infantil de México Federico Gómez, DF. maramedeiros@hotmail.com
Romero-Navarro
Benjamín
B
Valverde-Rosas
Saúl
S
Delgadillo
Rodolfo
R
Varela-Fascinetto
Gustavo
G
Muñoz-Arizpe
Ricardo
R
D000293:Adolescent; D000768:Anesthesia, General / Q000379:methods; D002102:Cadaver; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006776:Hospitals, Pediatric / Q000706:statistics & numerical data; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007223:Infant; D007431:Intraoperative Complications; D016030:Kidney Transplantation / Q000379:methods / Q000401:mortality / Q000706:statistics & numerical data; D019520:Living Donors / Q000706:statistics & numerical data; D008297:Male; D008800:Mexico / Q000453:epidemiology; D009392:Nephrectomy / Q000379:methods; D011183:Postoperative Complications; D014019:Tissue Donors
D007166:Immunosuppressive Agents